TL;DR
Get health and wellness essentials delivered free with Prime
- Fast, free delivery on millions of items
- Prime Video, Amazon Music and more included
- Member-only deals all year
A preprint study reports that transplanted hearts showed molecular aging patterns associated with recipients’ biological age, in mouse experiments and a small analysis of human biopsy samples. The work does not show that older hearts functionally become younger or that the findings should guide care; the report has not been peer-reviewed.
Researchers from teams at Brigham and Women’s Hospital and Harvard Medical School report that transplanted hearts showed molecular aging patterns associated with the recipient’s age, in mouse experiments and a small analysis of human samples. The findings, posted as a preprint that has not been peer-reviewed, raise questions about whether a recipient’s biological environment can influence a donor heart’s molecular profile, but do not establish that an older heart is clinically rejuvenated.
In the mouse experiments described in the bioRxiv preprint, researchers transplanted hearts between animals of different ages. The recipient kept its own heart, while the donor heart was attached to blood vessels in the neck. Four to six months later, the team examined DNA methylation biomarkers, which are used to estimate biological age. The analysis indicated that younger hearts in older recipients had age estimates above the donors’ age, while older hearts in younger recipients showed patterns consistent with a younger molecular profile.
According to the preprint, the researchers also examined changes in gene activity. Their analysis linked the age-associated patterns to inflammatory and interferon activity, as well as mitochondrial processes involved in energy production. These molecular changes varied with the age mismatch between donor and recipient. The study reports that the recipient’s own heart, liver and blood showed little change in biological age after the mouse transplants.
For a human comparison, the team analyzed archived biopsies from 11 transplant recipients, whose donor and recipient ages differed by between 24 years in one direction and 50 years in the other, the preprint reports. The estimated biological age of the transplanted hearts showed a pattern associated with recipient age. A separate analysis of cardiac outcomes in hundreds of recipients at one year after transplantation found associations between recipient age and several functional measures, most consistently exercise capacity. These clinical associations, reported in the preprint, do not establish that molecular age changes caused differences in function.
How Age Could Affect Donor Hearts
The findings address a practical question for transplant medicine: whether the age of a potential donor heart tells the whole story about how that organ may change after transplantation. A shortage of donor organs limits access to transplants, and programs have interest in expanding the pool of hearts considered suitable. The bioRxiv preprint suggests that the recipient’s systemic environment may affect a transplanted heart’s molecular aging markers, adding a possible factor for researchers to investigate.
That possibility remains far from a change in donor-selection practice. The study does not show that an older donor heart is safe or suitable for a recipient because its molecular profile may shift, nor does it show that molecular age predicts longer survival or better heart function. Its results may help shape further research, but the clinical value of these age markers is not established by the reported analyses.
Products Worth Considering
Fitbit Inspire 3 Health and Fitness Tracker Bundle
Fitbit Sense Health & Fitness Smartwatch (White/Gold, International Version)
Withings BPM Connect Wi-Fi and Bluetooth Blood Pressure Monitor
As an affiliate, we earn on qualifying purchases.
The Transplant Age Mismatch
Heart transplants increasingly involve donors and recipients of different ages, a practice described as heterochronic transplantation. There is no official upper age limit for heart donors, though donors younger than 45 are generally recommended, and relatively few programs accept hearts from people older than 50, according to the News-Medical report. Decisions about whether an organ can be transplanted depend on clinical evaluation and program criteria.
The News-Medical report also cites a rise in older recipients: in the United States, the number of transplant recipients aged 65 or above increased by 127% from 2010 to 2021. That figure describes recipients, not donor availability, and does not establish why the number changed. Earlier research into age-mismatched exposure to blood and other systemic factors had suggested that an older organism’s cells might show rejuvenation-related changes after exposure to a younger environment. The new work, described in the bioRxiv preprint, examines whether a similar pattern can be seen in transplanted hearts.
Limits of the Age Evidence
The findings are preliminary because the study is available as a bioRxiv preprint, which has not undergone peer review. The human biopsy analysis included only 11 recipients, and the reported association between recipient age and estimated heart age does not by itself demonstrate that recipient age caused the changes. The News-Medical report does not provide enough detail to assess the full range of patient characteristics or other factors that might affect the results.
It is also unclear whether changes in DNA methylation and gene activity correspond to meaningful improvements in heart health. The preprint does not establish that older hearts regain physical function, that recipients benefit from a shift in molecular markers, or that the heart’s age estimate predicts transplant outcomes. The mouse model, in which the recipient retained its own heart and received an additional heart, also differs from a standard human heart replacement.
Peer Review and Clinical Follow-Up
The next step is for the findings reported in the bioRxiv preprint to be evaluated through peer review and tested in larger studies. Researchers would need to establish whether the reported molecular patterns can be reproduced across more human recipients, and whether they track with clinically meaningful measures over time. Longer follow-up could help clarify whether age-associated changes in a transplanted heart relate to its function or to recipient outcomes.
Until such evidence is available, the study does not provide a basis for changing donor eligibility or transplant decisions. Its reported findings offer a research direction: examining how the recipient’s biological environment interacts with a donor heart after transplantation, while keeping molecular age estimates distinct from demonstrated clinical benefit.
Key Questions
What did the researchers find?
The bioRxiv preprint reports that transplanted hearts showed molecular aging patterns associated with recipient age in mouse experiments and an analysis of 11 human biopsy samples. Older hearts in younger recipients showed patterns consistent with a younger molecular profile.
Does this prove an older heart becomes younger?
No. The study measured molecular markers and gene activity. It does not establish that an older donor heart regains function or that its estimated biological age change improves a recipient’s health.
Can the findings change which donor hearts are accepted?
The findings do not establish new donor-selection guidance. The work is a preprint and has not been peer-reviewed; the News-Medical report says its results should not be treated as guidance for clinical practice.
How much human evidence was included?
The researchers analyzed archived heart biopsy samples from 11 transplant recipients, according to the bioRxiv preprint. They also examined cardiac outcomes in hundreds of recipients at one year, but those associations do not show that molecular age changes caused differences in outcomes.
Source: rss
